ConductScience.org, home

Paper36923400

The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles.

González-Rioja R and 3 others. Front Immunol, 2023. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles. Papers, record 36923400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923400

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles.
PubMed
Journal
Front Immunol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2026-01-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1González-Rioja RRamon
2Salazar VAVivian A
3Bastús NGNeus G
4Puntes VVictor

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
NanoparticlesMajor topic
Pulmonary SurfactantsMajor topic
Humans
Surface-Active Agents
RNA
Tissue Distribution
COVID-19 Vaccines
Lipids
SARS-CoV-2
Lipoproteins
Liposomes

Source PubMed

Download CSV of topics

References114

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120175529Ion release kinetics and particle persistence in aqueous nano-silver colloids.Environ Sci Technol2010https://conductscience.org/library/papers/20175529PubMed
28204648Liposome-induced activation of the classical complement pathway does not require immunoglobulin.Biochim Biophys Acta1994https://conductscience.org/library/papers/8204648PubMed
328153761ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.J Control Release2017https://conductscience.org/library/papers/28153761PubMed
426929620Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.Int J Nanomedicine2016https://conductscience.org/library/papers/26929620PubMed
520461061Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.Mol Ther2010https://conductscience.org/library/papers/20461061PubMed
635079274Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting.Nano Today2022https://conductscience.org/library/papers/35079274PubMed
720974237Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles.Int J Pharm2011https://conductscience.org/library/papers/20974237PubMed
826166403Rapid Synthesis of a Lipocationic Polyester Library via Ring-Opening Polymerization of Functional Valerolactones for Efficacious siRNA Delivery.J Am Chem Soc2015https://conductscience.org/library/papers/26166403PubMed
910699287Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.J Control Release2000https://conductscience.org/library/papers/10699287PubMed
1012739982Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.Clin Pharmacokinet2003https://conductscience.org/library/papers/12739982PubMed
1132786370The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.Bioconjug Chem2020https://conductscience.org/library/papers/32786370PubMed
128844203Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.Hum Gene Ther1996https://conductscience.org/library/papers/8844203PubMed
1330613436Advances in delivery systems for doxorubicin.J Nanomed Nanotechnol2018https://conductscience.org/library/papers/30613436PubMed
1425302857Nanosafety research--are we on the right track?Angew Chem Int Ed Engl2014https://conductscience.org/library/papers/25302857PubMed
1524345865Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles.Mol Ther Nucleic Acids2013https://conductscience.org/library/papers/24345865PubMed
1616862189Drug penetration in solid tumours.Nat Rev Cancer2006https://conductscience.org/library/papers/16862189PubMed
1721500814Aggregation and dissolution of 4 nm ZnO nanoparticles in aqueous environments: influence of pH, ionic strength, size, and adsorption of humic acid.Langmuir2011https://conductscience.org/library/papers/21500814PubMed
1819895862Nanosystem drug targeting: Facing up to complex realities.J Control Release2010https://conductscience.org/library/papers/19895862PubMed
1917658653Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.Adv Drug Deliv Rev2007https://conductscience.org/library/papers/17658653PubMed
2027508330Efficient Cellular Knockdown Mediated by siRNA Nanovectors of Gemini Cationic Lipids Having Delocalizable Headgroups and Oligo-Oxyethylene Spacers.ACS Appl Mater Interfaces2016https://conductscience.org/library/papers/27508330PubMed

See all 114 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41255464Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy.Int J Nanomedicine2025https://conductscience.org/library/papers/41255464PubMed
39763100Colloid-Forming Prodrug-Hydrogel Composite Prolongs Lower Intraocular Pressure in Rodent Eyes after Subconjunctival Injection.Adv Mater2025https://conductscience.org/library/papers/39763100PubMed
37689341The RLR intrinsic antiviral system is expressed in neural retina and restricts lentiviral transduction of human Mueller cells.Exp Eye Res2023https://conductscience.org/library/papers/37689341PubMed
37567502A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics.Adv Drug Deliv Rev2023https://conductscience.org/library/papers/37567502PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36923400

GET https://conductscience.org/api/papers/v1/36923400/references?page=2